Intraperitoneal lymphokine-activated killer-cell and interleukin-2 therapy for malignancies limited to the peritoneal cavity.Ronald G. Steis, John Edward McKnight, Louis A. VanderMolen et al.|Journal of Clinical Oncology|1990Cited by 106